187:
and prescription topical dermatology products. Botaneco produced, marketed, and sold its products under the brand name
Hydresia. In October 2009, Botaneco merged with Quebec City-based Advitech, a health sciences and technology company.
320:
Quote: "This partnership has not resulted in any financial benefit to SemBioSys to date and, as a result, the company has not transferred any intellectual property to the newly formed joint venture as of this
244:
317:
207:, China. The new company was structured as a Sino-Foreign Equity Joint Venture and seeks to develop and commercialize a variety of products including pharmaceutical, functional foods, and
263:
278:
164:
The company's strategy was to partner with other companies to enable the commercialization of products. Its lead pharmaceutical products under development were
353:
241:
183:
In 2007, SemBioSys formed a subsidiary, Botaneco
Specialty Ingredients Inc., dedicated to the commercialization of SemBioSys’ products for cosmetic,
211:
for China and the world. However SemBioSys did not transfer any intellectual property to the joint venture and Tasly terminated the agreement.
138:
302:
260:
203:(TCMs). Upon government approval, a new company called Tasly-SemBioSys Bio-Pharmaceuticals Co., Ltd. was incorporated in
200:
338:
220:
192:
154:
134:
333:
242:
Press release May 15, 2012: SemBioSys
Announces First Quarter Results and Provides Update on Activities
137:
spin-off (1994), SemBioSys became a publicly traded firm. Investors had included Bay City
Capital, the
199:(China) and its wholly owned subsidiary Tasly U.S. Tasly is of China's top five largest producers of
150:
146:
126:
106:
165:
142:
47:
306:
267:
248:
158:
122:
208:
130:
28:
172:. In a phase I/II clinical trial, SemBioSys demonstrated that its safflower produced
347:
299:
184:
169:
118:
99:
96:
103:
110:
204:
196:
177:
173:
53:
191:
In
October 2011, SemBioSys signed a collaboration agreement with
114:
84:
237:
235:
161:. In May 2012, SemBioSys terminated its operations.
80:
70:
60:
42:
34:
24:
261:Plant-derived insulin passes first human study
8:
19:
318:SenBioSys News Release 2012-04-04 07:31 ET
18:
231:
157:, Ventures West Capital Ltd., and Dr.
7:
180:, a commercially available insulin.
139:Business Development Bank of Canada
259:The Pharma Letter. 30 March 2009.
102:company. It utilized its patented
14:
354:Biotechnology companies of Canada
149:), Royal Bank Ventures Inc. (now
176:(SBS-1000) is bioequivalent to
66:James Szarko, President and CEO
279:Bloomberg BusinessWeek Profile
145:(a Canadian subsidiary of The
1:
201:traditional Chinese medicines
109:platform to develop and make
16:Definct biotechnology company
370:
305:February 16, 2015, at the
221:Plant-made pharmaceuticals
247:August 15, 2012, at the
95:was a development stage
93:SemBioSys Genetics Inc.
20:SemBioSys Genetics Inc.
300:Tasly Export Statement
266:June 27, 2010, at the
193:Tasly Pharmaceuticals
155:University of Calgary
135:University of Calgary
151:RBC Capital Partners
147:Dow Chemical Company
72:Number of employees
21:
166:biosimilar insulin
334:SemBioSys Website
90:
89:
85:www.sembiosys.com
361:
322:
315:
309:
297:
291:
287:
281:
276:
270:
257:
251:
239:
143:Dow AgroSciences
76:Approximately 20
48:Calgary, Alberta
22:
369:
368:
364:
363:
362:
360:
359:
358:
344:
343:
330:
325:
316:
312:
307:Wayback Machine
298:
294:
288:
284:
277:
273:
268:Wayback Machine
258:
254:
249:Wayback Machine
240:
233:
229:
217:
159:Maurice Moloney
133:industries. A
123:functional food
73:
63:
56:
50:
17:
12:
11:
5:
367:
365:
357:
356:
346:
345:
342:
341:
336:
329:
328:External links
326:
324:
323:
310:
292:
282:
271:
252:
230:
228:
225:
224:
223:
216:
213:
209:nutraceuticals
170:Apo AI(Milano)
131:pharmaceutical
88:
87:
82:
78:
77:
74:
71:
68:
67:
64:
61:
58:
57:
52:
46:
44:
40:
39:
36:
32:
31:
26:
15:
13:
10:
9:
6:
4:
3:
2:
366:
355:
352:
351:
349:
340:
339:Tasly Website
337:
335:
332:
331:
327:
319:
314:
311:
308:
304:
301:
296:
293:
289:
286:
283:
280:
275:
272:
269:
265:
262:
256:
253:
250:
246:
243:
238:
236:
232:
226:
222:
219:
218:
214:
212:
210:
206:
202:
198:
194:
189:
186:
185:personal care
181:
179:
175:
171:
167:
162:
160:
156:
152:
148:
144:
140:
136:
132:
128:
124:
120:
119:nutraceutical
116:
112:
108:
105:
101:
100:biotechnology
98:
94:
86:
83:
79:
75:
69:
65:
59:
55:
49:
45:
41:
38:Biotechnology
37:
33:
30:
27:
23:
313:
295:
285:
274:
255:
190:
182:
163:
97:agricultural
92:
91:
43:Headquarters
25:Company type
227:References
62:Key people
104:safflower
348:Category
303:Archived
264:Archived
245:Archived
215:See also
127:beverage
117:for the
111:proteins
107:pharming
35:Industry
205:Tianjin
197:Tianjin
178:humulin
174:insulin
153:), the
81:Website
321:date."
129:, and
54:Canada
29:Public
168:and
125:and
115:oils
113:and
195:of
350::
234:^
141:,
121:,
51:,
290:]
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.